It had been predicted mainly from structural and biophysical evidence that certain guanine nucleotide-rich sequences occurring along a strand of DNA (or RNA) could fold into specific, stable shapes. They would thus give rise to secondary structures, superimposed upon the regular helical structure of the strands. 1 The folds have been named "G-quadruplexes" because they form into two or more tetrads when four guanines are held in a planar arrangement through hydrogen bonds and other physiochemical interactions. Now, substantive evidence for another fold structure in hDNA has just recently been published. 5 In this case, cytosine-rich regions can form a stack of intercalated base pairs. This structure is called an "I-motif." Both types of folds, G-quadruplexes and I-motifs, are thought to play key regulatory roles in human genome physiology, and perhaps pathophysiology. We summarize the information about folded DNA and, in particular, how they might provide novel drugdiscovery targets, most likely for cancer, but perhaps also for otherstill unanticipated-therapeutic applications.
Summary
What is known and objective: The double-helical conformation of human DNA (hDNA) is so axiomatic that it is called the "canonical" form. Recently, though, intrastrand folds ("I-motifs" and "G-quadruplexes") have been identified in hDNA. These could be targets for novel drug discovery. What is new and conclusion: The newly identified "folded DNA" structures ("I-motifs" and "G-quadruplexes") could represent novel drug-discovery targets, most likely for cancer.
K E Y W O R D S
cancer, drug target, folded DNA, G-quadruplex, I-motif
| G-folds
The stability of G-quadruplexes under near-physiological conditions suggested that they could be present in genomic DNA. 6 Their demonstration in human cells was important, because such folds are thought to be associated with-or to have regulatory roles in-a variety of important aspects of either normal genome functioning, such as transcription, recombination and replication, 7-10 or pathophysiology, such as cancer. They can occur at more than 370 000 sites in the human genome.
11
A guanine-rich sequence consisting of only three adjacent guanines can form a fold, in this case a stack consisting of a central guanine hydrogen-bonded to two other guanines. 12, 13 These may constitute independent folds, or they might instead be intermediates that are formed during the folding and unfolding of G-quadruplexes. 14 The formation of G-triplex structures is promoted by Na + , K + , Ca 2+ and Mg 2+ (the effect of bivalent cations is specific for triplexes, and they do not promote formation of G-quadruplexes). 15 Biffi et al 3 generated an "engineered, structure-specific" anti- 
| I-folds
Intercalated motif ("I-motif") structures are less studied than Gquadruplexes. They are formed by a stack of intercalated neutral cysteine base pairs. C-rich regions are common in the human genome. Using a range of biophysical techniques, both intra-and intermolecular structures were originally characterized in vitro.
16-19
Recently, Zeraati et al The cell-cycle-specific sequence of formation of I-motifs is thus distinctly different from that of G-quadruplexes (I-motifs during G1, and G-quadruplexes during the S phase). Further, the occurrence of I-motifs and quadruplexes is often mutually exclusive. 21 This has led to the suggestion that they play opposite functional roles in the regulation of gene expression. 22 
| Potential drug targets
The nonrandom distribution of DNA folds within the human genome, 23 
29-31
In addition, DNA folds have been implicated in neurological diseases, 32 (Figure 1) . 37 To date, more than 1000 such ligands consisting of various chemotypes have been reported. 38 The hope is that ligands can achieve sufficient specificity to recognize unique (normal or aberrant) fold conformations for each disease and individual therapeutic (personalized medicine) purposes.
| WHAT IS NE W AND CON CLUS I ON
For many years, the canonical double-helix structure of DNA was thought to be the only structure that allowed, and indeed dictated, normal physiological function. It is now known that noncanonical DNA folds are normal structures, with regulatory roles and implications for disease. 39, 40 Folds such as the G-quadruplexes and I-motifs were originally identified using a variety of in vitro techniques.
Recent studies have identified DNA folds in human cells, in the human genome. They are now a part of a growing family of diverse noncanonical DNA folds. 41, 42 Although the identification of DNA folds in the human genome is only relatively recent, the list of implicated diseases is still being elucidated-but is already growing.
Therapeutic interventions and selective ligands appear to be possible and should represent a sea change in pharmacotherapy of DNA fold-related diseases.
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